{"version":"1.0","type":"link","title":"TIGOS Trial: A Randomized, Double-Blind, Phase III Trial of Atigotatug and Nivolumab Fixed-Dose Combination With Chemotherapy Versus Atezolizumab With Chemotherapy as First-Line Therapy in Patients With Extensive-Stage Small Cell Lung Cancer.","author_name":"Paz-Ares LG 외","author_url":"https://prs-insight.online/author/Paz-Ares%20LG","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/96317","thumbnail_width":1200,"thumbnail_height":630}